Tumor Infiltrating Macrophages as a Potential Predictive Biomarker of Response to 5-FU in Patients With Microsatellite-Stable Colorectal Cancer

被引：0
|
作者：
Laghi, Luigi
Bianchi, Paolo
Grizzi, Fabio
Di Caro, Giuseppe
Celesti, Giuseppe
Roncalli, Massimo
Mantovani, Alberto
Malesci, Alberto
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S531 / S531
页数：1
相关论文
共 50 条
  • [21] 5-FU schedules, serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancer
    Blaschke, Martina
    Cameron, Silke
    Goeschen, Colin
    Ramadori, Giuliano
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 56 - 58
  • [22] Synthesis and Chemopreventive Potential of 5-FU/Genistein Hybrids on Colorectal Cancer Cells
    Moreno-Quintero, Gustavo
    Castrillon-Lopez, Wilson
    Herrera-Ramirez, Angie
    Yepes-Perez, Andres F.
    Quintero-Saumeth, Jorge
    Cardona-Galeano, Wilson
    PHARMACEUTICALS, 2022, 15 (10)
  • [23] 5-FU based chemotherapy with Bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor
    Gruenberger, B.
    Starlinger, P.
    Messinger, E.
    Weibrecht, S.
    Jan, P. Jonas
    Weitmayr, B.
    Gruenberger, T.
    ANNALS OF ONCOLOGY, 2016, 27 : 47 - 48
  • [24] Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?
    Hamid, Marwa Abdel
    Pammer, Lorenz M.
    Lentner, Theresa K.
    Doleschal, Bernhard
    Gruber, Rebecca
    Kocher, Florian
    Gasser, Elisabeth
    Joebstl, Anna
    Seeber, Andreas
    Amann, Arno
    CURRENT ONCOLOGY REPORTS, 2024, 26 (10) : 1258 - 1270
  • [25] Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
    Gamelin, EC
    DanquechinDorval, EM
    Dumesnil, YF
    Maillart, PJ
    Goudier, MJ
    Burtin, PC
    Delva, RG
    Lortholary, AH
    Gesta, PH
    Larra, FG
    CANCER, 1996, 77 (03) : 441 - 451
  • [26] An RNA damage response network mediates the lethality of 5-FU in colorectal cancer
    Chen, Jung-Kuei
    Merrick, Karl A.
    Kong, Yi Wen
    Izrael-Tomasevic, Anita
    Eng, George
    Handly, Erika D.
    Patterson, Jesse C.
    Cannell, Ian G.
    Suarez-Lopez, Lucia
    Hosios, Aaron M.
    Dinh, Anh
    Kirkpatrick, Donald S.
    Yu, Kebing
    Rose, Christopher M.
    Hernandez, Jonathan M.
    Hwangbo, Haeun
    Palmer, Adam C.
    Heiden, Matthew G. Vander
    Yilmaz, Omer H.
    Yaffe, Michael B.
    CELL REPORTS MEDICINE, 2024, 5 (10)
  • [27] Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy
    Li, Ziyu
    Jia, Yongning
    Zhu, Honglin
    Xing, Xiaofang
    Pang, Fei
    Shan, Fei
    Li, Shuangxi
    Wang, Danhua
    Zhao, Fangping
    Ma, Tonghui
    Wang, Sizhen
    Ji, Jiafu
    GASTRIC CANCER, 2021, 24 (06) : 1342 - 1354
  • [28] Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy
    Ziyu Li
    Yongning Jia
    Honglin Zhu
    Xiaofang Xing
    Fei Pang
    Fei shan
    Shuangxi Li
    Danhua Wang
    Fangping Zhao
    Tonghui Ma
    Sizhen Wang
    Jiafu Ji
    Gastric Cancer, 2021, 24 : 1342 - 1354
  • [29] Metabolic Singularities in Microsatellite-Stable Colorectal Cancer: Identifying Key Players in Immunosuppression to Improve the Immunotherapy Response
    Gorria, Teresa
    Sierra-Boada, Marina
    Rojas, Mariam
    Figueras, Carolina
    Marin, Silvia
    Madurga, Sergio
    Cascante, Marta
    Maurel, Joan
    CANCERS, 2025, 17 (03)
  • [30] Plasma concentrations of 5-FU and creatinine clearance as predictive markers for severe toxicities of capecitabine in patients with colorectal cancer
    Makihara, Katsuya
    Mishima, Hideyuki
    Azuma, Sayaka
    Miyagi, Kazuyo
    Komori, Katsuya
    Hasegawa, Hiroko
    Yasui, Masayoshi
    Ikenaga, Masakazu
    Tsujinaka, Toshimasa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345